суббота, 18 марта 2017 г.

Cholesterol drug cuts heart risks, spurs new debate on cost

Cholesterol drug cuts heart risks, spurs new debate on cost


This undated image provided by Amgen Inc. shows the drug Repatha. The medicine cut the chances of having a heart attack or some other serious problems by 15 to 20 percent in a big study of people at high risk for those problems, released Friday, March 17, 2017, at an American College of Cardiology conference in Washington.



from Biotech News